MDM2 and chronic myelogenous leukemia, BCR-ABL1 positive: In hematological malignancies, the MDM2 SNP309 G-allele is associated with increased risk for acute myeloid leukemia (AML) and chronic myelogenous leukemia (CML) [20, 21].